People

Saba Rouhani
Saba Rouhani, PhD, MSc
NYU School of Global Public Health - Assistant Professor
Email: saba.rouhani@nyu.edu
Education
PhD, Global Disease Epidemiology & Control, Johns Hopkins Bloomberg School of Public Health
MSc, Control of Infectious Diseases, London School of Hygiene & Tropical Medicine
BSc Medical Microbiology, University of Edinburgh
BIO
Saba Rouhani is an Assistant Professor in the Department of Epidemiology. Her research is focused on epidemiology of overdose and other drug-related harms within the context of changing drug and criminal justice policies. She is particularly interested in characterizing reforms to policing and prosecution of people who use drugs, and measuring their impacts on health outcomes. Dr. Rouhani’s research has been published in the International Journal of Drug Policy, Drug and Alcohol Dependence, Journal of Urban Health, American Journal of Public Health and Preventive Medicine.

Dr. Rouhani completed a T32 Drug Dependence Epidemiology Training fellowship funded by the National Institutes of Health/National Institute on Drug Abuse in 2020 and worked as research faculty in the Department of Health, Behavior and Society at the Johns Hopkins Bloomberg School of Public Health prior to joining NYU.
Projects
Principal Investigator, Law Enforcement Perspectives and Experiences of the Changing Drug Policy Landscape: A Qualitative Study with Baltimore City Police Officers. Completed
Publications

Recent

Bailey A, Andraka-Christou B, Rouhani S, Clark MH, Atkins D, del Pozo B (2025).
Beliefs of US chiefs of police about substance use disorder, fentanyl exposure, overdose response, and use of discretion: Results from a national survey
Health and Justice, 13 (1), 13. doi: 10.1186/s40352-025-00318-8. PMCID: PMC11881252.

Tomko C, Rouhani S, Johnson RM, Susukida R, Byregowda H, Parnham T, Schneider KE, Gibson M, Heath T, Rickard R, Boyd CE, Park JN (2025).
Implementation of overdose prevention in Maryland: Implications for resource allocation, program scale-up, and evaluation
Health Promotion Practice, 26 (2), 332-341. doi: 10.1177/15248399231209935.

Mauri AI, Rouhani S, Purtle J (2025).
Characterizing crisis services offered by certified community behavioral health clinics: Results from a national survey
Psychiatric Services, 76 (1), 13-21. doi: 10.1176/appi.ps.20240152.

Sisson LN, Tomko C, Rouhani S, Sherman SG (2025).
Examining the association between psychological resilience and chronic versus discrete stressors among individuals who use opioids in Baltimore, Maryland
Drug and Alcohol Review, 44 (1), 288-297. doi: 10.1111/dar.13959. PMCID: PMC11745933.

del Pozo B, Rouhani S, Bailey A, Clark MH, Martins KF, Ahmed FZ, Atkins D, Andraka-Christou B (2024).
The effects of message framing on US police chiefs’ support for interventions for opioid use disorder: A randomized survey experiment
Health and Justice, 21 (1), 50. doi: 10.1186/s40352-024-00306-4. PMCID: PMC11660544.


Notable

Rouhani S, Schneider KE, Rao A, Urquhart GJ, Morris M, LaSalle L, Sherman SG (2021).
Perceived vulnerability to overdose-related arrests among people who use drugs in Maryland
International Journal of Drug Policy, 98, 103426. doi: 10.1016/j.drugpo.2021.103426.

Rouhani S, Decker MR, Tomko C, Silberzahn B, Allen ST, Park JN, Footer KHA, Sherman SG (2021).
Resilience among cisgender and transgender women in street-based sex work in Baltimore, Maryland
Womens Health Issues, 31 (2), 148-156. doi: 10.1016/j.whi.2020.11.002. PMCID: PMC8005437.

Rouhani S, Park JN, Morales KB, Green TC, Sherman SG (2020).
Trends in opioid initiation among people who use opioids in three US cities
Drug and Alcohol Review, 39 (4), 375-383. doi: 10.1111/dar.13060.

Dr. Rouhani's ORCID Profile